Trial Profile
Phase 1, Open-Label Study Of The Pharmacokinetics, Non-Renal Clearance And Dialyzability Of CP-690,550 In Subjects With End-Stage Renal Disease Undergoing Hemodialysis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Apr 2015
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary)
- Indications Kidney disorders
- Focus Pharmacokinetics
- Sponsors Pfizer
- 28 Apr 2015 New trial record